Skip to content

GILD

Gilead Sciences, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$31.0B+3.6%
Gross profit$24.8B+2.9%
Operating income−$2.4B+19.7%
Net income−$3.9B+133.3%
EPS−$3.16+132.4%
Free cash flow$13.8B+4.7%